Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117832 · ClinicalTrials.gov registry record · NA
Nasal Ocular Reflexes Contribute to Eye Symptoms
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00117832 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT00117832, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Eye symptoms of tearing, redness and itching frequently occur in patients with allergic rhinitis or hayfever. The purpose of this trial is to study whether placing an allergen (a substance that causes allergies) directly in your nose can cause you to have eye symptoms as well as nasal symptoms.
Interventions
- DRUG Azelastine nasal spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117832
The ClinicalTrials.gov registry entry for NCT00117832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Azelastine nasal spray is the first listed.
NCT00117832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117832 about?
NCT00117832 is a clinical study titled "Nasal Ocular Reflexes Contribute to Eye Symptoms". Eye symptoms of tearing, redness and itching frequently occur in patients with allergic rhinitis or hayfever. The purpose of this trial is to study whether placing an allergen (a substance that causes allergies) directly in your nose can cause you to have eye symptoms as well as nasal symptoms.
What is the current status of trial NCT00117832?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2005-03. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00117832?
The interventions under investigation include: Azelastine nasal spray (DRUG).
Who is sponsoring clinical trial NCT00117832?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.